tiprankstipranks
Blurbs

Analysts Have Conflicting Sentiments on These Healthcare Companies: Anika Therapeutics (ANIK) and Galecto (GLTO)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Anika Therapeutics (ANIKResearch Report) and Galecto (GLTOResearch Report).

Anika Therapeutics (ANIK)

Barrington analyst Michael Petusky maintained a Hold rating on Anika Therapeutics today. The company’s shares closed last Wednesday at $24.68.

According to TipRanks.com, Petusky is a 5-star analyst with an average return of 8.8% and a 52.6% success rate. Petusky covers the Healthcare sector, focusing on stocks such as Merit Medical Systems, ATI Physical Therapy, and US Physical Therapy.

The word on The Street in general, suggests a Hold analyst consensus rating for Anika Therapeutics.

See Insiders’ Hot Stocks on TipRanks >>

Galecto (GLTO)

SVB Securities analyst Mike Kratky maintained a Buy rating on Galecto yesterday and set a price target of $13.00. The company’s shares closed last Wednesday at $1.72, close to its 52-week low of $1.17.

According to TipRanks.com, Kratky is a 1-star analyst with an average return of -10.4% and a 0.0% success rate. Kratky covers the Healthcare sector, focusing on stocks such as Pliant Therapeutics, Kymera Therapeutics, and Morphic Holding.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Galecto with a $13.00 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on ANIK:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More